Exploring Gut Microbiota in Systemic Lupus Erythematosus: Insights and Biomarker Discovery Potential
- PMID: 40216660
- DOI: 10.1007/s12016-025-09051-4
Exploring Gut Microbiota in Systemic Lupus Erythematosus: Insights and Biomarker Discovery Potential
Abstract
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease characterized by chronic inflammation and multi-organ damage, influenced by genetic, environmental, and immunological factors. Recent research highlights the significant role of gut microbiota in the pathogenesis and progression of SLE, suggesting that dysbiosis-an imbalance in the microbial community-can contribute to disease onset and severity. The gut microbiota, through its metabolites, interacts with the host's immune system, influencing immune responses and maintaining intestinal barrier integrity. These interactions have positioned the gut microbiota as a potential source of diagnostic biomarkers and therapeutic targets for SLE. This review delves into the mechanisms by which gut microbiota influences SLE, exploring how alterations in microbial composition and function can trigger autoimmune responses. We also examine the potential of gut microbiota-derived metabolites as biomarkers for early diagnosis and disease progression monitoring. Additionally, the therapeutic implications of modulating gut microbiota through dietary interventions, probiotics, prebiotics, and other microbiota-targeted therapies are discussed as promising strategies for managing SLE. The findings suggest that a deeper understanding of the gut microbiota's role in SLE could lead to more personalized and effective treatments, potentially transforming the approach to managing this chronic autoimmune condition. Future research should focus on elucidating the precise mechanisms of gut microbiota interaction with the immune system and its impact on SLE, as well as validating gut microbiota-based biomarkers and therapies in clinical settings.
Keywords: Autoimmune disease; Biomarkers; Cytokines; Gut Microbiota dysbiosis; Inflammatory Microenvironment; Metabolic Disorders; Systemic Lupus Erythematosus.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval and Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests. Figures were created with biorender.com .
Similar articles
-
Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention.Front Immunol. 2021 Jul 15;12:686501. doi: 10.3389/fimmu.2021.686501. eCollection 2021. Front Immunol. 2021. PMID: 34335588 Free PMC article. Review.
-
Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies.Front Immunol. 2021 Dec 3;12:799788. doi: 10.3389/fimmu.2021.799788. eCollection 2021. Front Immunol. 2021. PMID: 34925385 Free PMC article. Review.
-
Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus.Front Immunol. 2023 Jul 18;14:1202850. doi: 10.3389/fimmu.2023.1202850. eCollection 2023. Front Immunol. 2023. PMID: 37533870 Free PMC article. Review.
-
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus.Curr Rheumatol Rep. 2023 Jun;25(6):107-116. doi: 10.1007/s11926-023-01102-z. Epub 2023 Apr 21. Curr Rheumatol Rep. 2023. PMID: 37083877 Review.
-
The role of microbiota and oxidative stress axis and the impact of intravenous immunoglobulin in systemic lupus erythematosus.Autoimmun Rev. 2024 Sep;23(9):103607. doi: 10.1016/j.autrev.2024.103607. Epub 2024 Aug 24. Autoimmun Rev. 2024. PMID: 39187222 Review.
Cited by
-
Extracellular Vesicles Derived From Streptococcus anginosus Aggravate Lupus Nephritis by Triggering TLR2-MyD88-NF-κB Signalling in NK Cells.J Extracell Vesicles. 2025 Jul;14(7):e70134. doi: 10.1002/jev2.70134. J Extracell Vesicles. 2025. PMID: 40673809 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical